Schizophrenia Research Forum - A Catalyst for Creative Thinking


van Hes R, Smid P, Stroomer CN, Tipker K, Tulp MT, Van Der Heyden JA, McCreary AC, Hesselink MB, Kruse CG. SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition. Bioorg Med Chem Lett. 2003 Feb 10 ; 13(3):405-8. Pubmed Abstract